DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Diazepam (Diazepam) - Adverse Event Reports - Life Threatening Events - Confusional State

 



Index of reports > Cases resulting in life threatening events (14) > Cases with Confusional State (4)

Below is the selection of adverse event reports related to Diazepam that includes cases resulting in life threatening events where reactions include confusional state.

Adverse event in 35 year old male receiving Diazepam

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-31

Patient: 35 year old male

Adverse reactions / side effects: Confusional State, Hepatic Encephalopathy, Oesophageal Haemorrhage

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Diazepam
    Dosage: 12 mg (4 mg, 3 in 1 d) oral
    Administration route: Oral
    End date: 2007-10-05

Fentanyl
    Dosage: (75 mcg, 1 hour) transdermal
    End date: 2007-10-05

Temazepam
    Dosage: (10 mg) oral
    Administration route: Oral
    End date: 2007-10-05

Tramadol
    Dosage: (100 mg, as required) oral
    Administration route: Oral
    End date: 2007-10-05



Adverse event in 35 year old male receiving Diazepam

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-29

Patient: 35 year old male

Adverse reactions / side effects: Confusional State, Hepatic Encephalopathy, Oesophageal Haemorrhage

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Diazepam
    Dosage: 4mg, three times daily
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-10-05

Durogesic (Fentanyl), Clopiramine, Fentanyl)
    Dosage: 75 ug, 1 hour
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-10-05

Temazepam
    Dosage: 10mg
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-10-05

Tramadol HCL
    Dosage: 100mg, as necessary
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-10-05

Other drugs received by patient: Amoxicillin; Buscopan (Hyoscine Butylbromide) (Hyoscine Butylbromide); Citalopram Hydrobromide; Cyclizine (Cyclizine) (Cyclizine); Omeprazole; Paracetamol (Paracetamol) Paracetamol); Tegretol Retard (Carbamazepine) (Carbamazepine)



Adverse event in 35 year old male receiving Diazepam

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-25

Patient: 35 year old male, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Confusional State, Hepatic Encephalopathy, Oesophageal Haemorrhage

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Diazepam
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Duragesic-100
    Indication: Drug USE FOR Unknown Indication

Temazepam
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Tramadol HCL
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Amoxicillin; Buscopan; Citalopram Hydrobromide; Cyclizine; Omeprazole; Paracetamol; Tegretol Retard



Adverse event in male receiving Diazepam

Reported by a physician from Germany on 2007-07-16

Patient: male, weighing 71.0 kg (156.2 pounds)

Adverse reactions / side effects: Confusional State, Inappropriate Schedule of Drug Administration, Coordination Abnormal, Fall

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Citalopram Hydrobromide
    Administration route: Oral
    Indication: Depression

Diazepam
    Administration route: Oral
    Indication: Sleep Disorder

Duragesic-100
    Indication: Metastatic Pain

Valoron
    Administration route: Oral
    Indication: Cancer Pain

Other drugs received by patient: Aspirin; Kreon; Kreon; Pantozol; Amlodipine; Folic Acid; Methotrexat

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009